HUMATIN Drug Patent Profile
✉ Email this page to a colleague
When do Humatin patents expire, and when can generic versions of Humatin launch?
Humatin is a drug marketed by King Pfizer, Parkedale, and Parke Davis. and is included in three NDAs.
The generic ingredient in HUMATIN is paromomycin sulfate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the paromomycin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Humatin
A generic version of HUMATIN was approved as paromomycin sulfate by HERITAGE on December 14th, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HUMATIN?
- What are the global sales for HUMATIN?
- What is Average Wholesale Price for HUMATIN?
Summary for HUMATIN
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 27 |
| Patent Applications: | 5,380 |
| DailyMed Link: | HUMATIN at DailyMed |
US Patents and Regulatory Information for HUMATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pfizer | HUMATIN | paromomycin sulfate | CAPSULE;ORAL | 062310-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parkedale | HUMATIN | paromomycin sulfate | CAPSULE;ORAL | 060521-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | HUMATIN | paromomycin sulfate | SYRUP;ORAL | 060522-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
